Cargando…

The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis

Chronic hepatitis B virus (HBV) infection poses a serious public health problem in many parts of the world. Presently, even with proper joint immunoprophylaxis, approximately 10-15% of newborns from HBV carrier mothers suffer from HBV infection through intrauterine transmission. One of the risk fact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Min, Zhou, Xin, Gao, Sheng, Yang, Shi-Gui, Wang, Bing, Chen, Hua-Zhong, Ruan, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494585/ https://www.ncbi.nlm.nih.gov/pubmed/22947333 http://dx.doi.org/10.1186/1743-422X-9-185

Ejemplares similares

Telbivudine Treatment during Late Pregnancy Prevents Mother-to-Child Transmission of Hepatitis B Virus: A Retrospective Study
por: Cai, Mengzhi, et al.
Publicado: (2019)

Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice
por: Zhang, Hua, et al.
Publicado: (2014)

Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy
por: Zeng, Jianyong, et al.
Publicado: (2019)

Telbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission: Outcomes of telbivudine treatment during pregnancy
por: Tan, Zhangmin, et al.
Publicado: (2016)

Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis
por: Liu, Min-Hui, et al.
Publicado: (2013)

Efficacy and safety of telbivudine treatment for the prevention of HBV perinatal transmission
por: Ren, Cuicui, et al.
Publicado: (2020)

Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study
por: Li, Zhenhua, et al.
Publicado: (2020)

Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation
por: Han, Li-fen, et al.
Publicado: (2019)

Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus
por: Zhu, Bo, et al.
Publicado: (2021)

Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission
por: Sun, Weihui, et al.
Publicado: (2017)

Safety and efficacy of telbivudine for the treatment of chronic hepatitis B
por: Osborn, Melissa K
Publicado: (2009)

Effectiveness of telbivudine antiviral treatment in patients with hepatitis B virus-associated glomerulonephritis: A 104-week pilot study
por: Yan, Zhaoping, et al.
Publicado: (2018)

Comparing the Efficacy and Safety of Treating Chronic Hepatitis B Infection during Pregnancy with Lamivudine, Telbivudine, and Tenofovir: A Meta-analysis
por: Sali, Shahnaz, et al.
Publicado: (2019)

Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine
por: Cai, Shaohang, et al.
Publicado: (2017)

Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study
por: Liang, Jian, et al.
Publicado: (2013)

Effects of Telbivudine Treatment on the Circulating CD4(+) T-Cell Subpopulations in Chronic Hepatitis B Patients
por: Zheng, Yanhua, et al.
Publicado: (2012)

Composition and Interactions of Hepatitis B Virus Quasispecies Defined the Virological Response During Telbivudine Therapy
por: Zhou, Bin, et al.
Publicado: (2015)

Hepatitis B virus genotype is an independent prognostic factor of telbivudine and tenofovir treatment in hepatitis B surface antigen‐positive pregnant women
por: Zhang, Baofang, et al.
Publicado: (2021)

Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B
por: Kim, Eun Hye, et al.
Publicado: (2013)

Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature
por: Zheng, Jinxin, et al.
Publicado: (2017)

Clinicopathological Features of Telbivudine-Associated Myopathy
por: Ambang, Tomica, et al.
Publicado: (2016)

Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections
por: Lin, Ming-Tsung, et al.
Publicado: (2013)

Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial
por: An, Jihyun, et al.
Publicado: (2017)

No intrauterine vertical transmission in pregnancy with COVID-19: A case report
por: Lv, Yantian, et al.
Publicado: (2020)

Infant immune response to hepatitis B vaccine after fetal exposure to telbivudine
por: Li, Yandi, et al.
Publicado: (2022)

Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus
por: Wang, Wenjun, et al.
Publicado: (2016)

Baseline Prognostic Factors and Statistic Model to Predict Early Virological Response in Telbivudine-Treated Patients With Chronic Hepatitis B
por: Zhou, Rui, et al.
Publicado: (2013)

Developmental consequences of children born from mothers with telbivudine treatment during late pregnancy: A prospective study with 3-year follow-up
por: Yi, Wei, et al.
Publicado: (2021)

Undetectable intrauterine transmission during the first trimester of pregnancy in woman after COVID-19 infection
por: Xu, Jian, et al.
Publicado: (2023)

Pegylated interferon/telbivudine sequential therapy in Hepatitis Be antigen negative severe chronic hepatitis B patient
por: Caroleo, Benedetto, et al.
Publicado: (2013)

Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review
por: Zhao, Shushan, et al.
Publicado: (2010)

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
por: Wang, Y, et al.
Publicado: (2013)

Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure
por: Malakar, Debraj, et al.
Publicado: (2021)

Myotoxicity of telbivudine in pre-existing muscle damage
por: Finsterer, Josef, et al.
Publicado: (2010)

Intrauterine Bakri balloon tamponade plus cervical cerclage for the prevention and treatment of postpartum haemorrhage in late pregnancy complicated with acute aortic dissection: Case series
por: Peng, Mei, et al.
Publicado: (2021)

Motor development delay in offspring is associated with prenatal telbivudine exposure
por: Zhou, Chengliang, et al.
Publicado: (2018)

Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B
por: Ying, Yue, et al.
Publicado: (2018)

Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA
por: Kim, Dong Hyun, et al.
Publicado: (2017)

Hepatitis B Virus Infection during Pregnancy: Transmission and Prevention
por: Navabakhsh, Behrouz, et al.
Publicado: (2011)

Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysis
por: Wu, Xiaolu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lnkqnvbhqsjndghb9rmr7tjaai